Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 59 holding rows worth $172,735,000.

Accession
0001493152-15-005571
Filed
2015-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 59 entries on the cover page, a total value of $172,735,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,735,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMICUS THERAPEUTICS INC03152W109COM1,404,667$19,651,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,880,004$10,547,000thousands by filing date
NEURODERM LTDM74231107ORD SHS496,630$10,265,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR469,893$8,317,000thousands by filing date
iShares Russell 2000 ETF464287655SHS70,000$7,645,000thousands by filing dateput
Lion Biotechnologies53619R102COM1,314,959$7,574,000thousands by filing date
BIOTELEMETRY INC090672106COM450,000$5,508,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR313,524$5,070,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH70,000$4,357,000thousands by filing dateput
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK400,000$4,296,000thousands by filing date
VERACYTE INC COM92337F107Stock905,000$4,244,000thousands by filing date
RRSAT GLOBAL COMM NTWRK LTDM8183P102SHS469,350$3,849,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM1,108,719$3,504,000thousands by filing date
Innocoll45780Q103SPONDS ADR273,981$3,430,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2122,222$3,397,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR351,261$3,337,000thousands by filing date
CAS MED SYS INC124769209COM2,547,299$3,184,000thousands by filing date
WEBMD HEALTH CORP94770V102COM79,702$3,175,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock271,399$3,094,000thousands by filing date
SPECTRANETICS CORP84760C107COM260,000$3,065,000thousands by filing date
IRIDEX CORP462684101COM397,196$3,023,000thousands by filing date
SPECTRANETICS CORP84760CAA5MTNF 2.625% 6/04,000,000$3,020,000thousands by filing dateprincipal
IMMUNOMEDICS INC452907108COM1,711,067$2,943,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM221,138$2,906,000thousands by filing date
BUILD-A-BEAR WORKSHOP INC120076104COM152,876$2,888,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM182,618$2,800,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK300,000$2,517,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS184,746$2,494,000thousands by filing date
AGENUS INC00847G705COM NEW510,000$2,346,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock480,020$2,189,000thousands by filing date
ALIMERA SCIENCES INC016259103COM974,318$2,153,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM140,000$1,809,000thousands by filing date
EPIZYME INC29428V104COM140,000$1,800,000thousands by filing date
ESSA PHARMA INC29668H104COM288,400$1,797,000thousands by filing date
ZAFGEN INC98885E103COM51,519$1,646,000thousands by filing date
CARROLS RESTAURANT GROUP INC14574X104COM128,643$1,531,000thousands by filing date
CUTERA INC232109108COM116,921$1,529,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM15,000$1,379,000thousands by filing datecall
BIODELIVERY SCIENCES INTL IN09060J106COM212,100$1,179,000thousands by filing date
BIODEL INC09064M204COM2,548,830$1,121,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock377,427$1,072,000thousands by filing date
FLEX PHARMA INC33938A105COM88,716$1,065,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM31,744$1,019,000thousands by filing date
COMBIMATRIX CORPORATION20009T303COM NEW893,644$1,001,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM141,309$952,000thousands by filing date
ISHARES INC464286103MSCI AUST ETF50,000$896,000thousands by filing dateput
CELLADON CORP15117E107Cmn819,710$861,000thousands by filing date
CARDIOME PHARMA CORP14159U301COM NO PAR92,397$780,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock59,127$752,000thousands by filing date
CARDICA INC14141R101COM1,849,436$499,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK200,000$494,000thousands by filing date
Ocugen43358V109Common123,249$491,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM111,342$451,000thousands by filing date
CEMPRA INC15130J109COM15,000$418,000thousands by filing date
ORGANOVO HOLDINGS INC68620A104COMMON120,000$322,000thousands by filing dateput
Adobe Systems Inc98979H103COM73,826$292,000thousands by filing date
ARROWHEAD RESEARCH CORP042797209COM50,000$288,000thousands by filing dateput
KINDRED BIOSCIENCES INC COM494577109Stock50,000$260,000thousands by filing date
Accelerate Diagnostics00430H102COM15,000$243,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-15-005571this filing2015-11-16acceptance time not in the bulk data set